Published in Ann Neurol on September 01, 1997
Network modulation in the treatment of Parkinson's disease. Brain (2006) 2.52
High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model. J Comput Neurosci (2004) 2.33
Medication and subthalamic nucleus deep brain stimulation similarly improve balance and complex gait in Parkinson disease. Parkinsonism Relat Disord (2012) 1.98
Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2010) 1.93
Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics (2008) 1.42
Resting state functional MRI in Parkinson's disease: the impact of deep brain stimulation on 'effective' connectivity. Brain (2014) 1.10
Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism. J Neurol Neurosurg Psychiatry (1999) 1.07
Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease. Exp Brain Res (2004) 1.05
Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease. Exp Neurol (2008) 0.99
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's disease. Exp Brain Res (2006) 0.97
High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat. Exp Brain Res (2007) 0.94
Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 0.93
Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol (2009) 0.93
The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson's patients. Parkinsonism Relat Disord (2008) 0.91
Mechanisms of unilateral STN-DBS in patients with Parkinson's disease : a PET study. J Neurol (2008) 0.91
Therapeutic subthalamic nucleus deep brain stimulation reverses cortico-thalamic coupling during voluntary movements in Parkinson's disease. PLoS One (2012) 0.90
Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease. Neurosci Biobehav Rev (2013) 0.90
Cortical potentials evoked by deep brain stimulation in the subthalamic area. Front Syst Neurosci (2011) 0.88
Deep brain stimulation: are astrocytes a key driver behind the scene? CNS Neurosci Ther (2014) 0.86
The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI. PLoS One (2012) 0.85
Hypoactivation of the primary sensorimotor cortex in de novo Parkinson's disease : a motor fMRI study under controlled conditions. Neuroradiology (2011) 0.84
Modulation of human time processing by subthalamic deep brain stimulation. PLoS One (2011) 0.84
Dopaminergic modulation of emotional conflict in Parkinson's disease. Front Aging Neurosci (2014) 0.83
Distributed neural actions of anti-parkinsonian therapies as revealed by PET. J Neural Transm (Vienna) (2005) 0.83
Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus. Front Syst Neurosci (2011) 0.83
Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method. Surg Radiol Anat (2005) 0.83
Retracted Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy. Korean J Radiol (2002) 0.82
Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinson's disease: what have we learned from neuroimaging studies? Brain Connect (2013) 0.82
Imaging basal ganglia function. J Anat (2000) 0.81
Deep brain stimulation and medication for parkinsonian tremor during secondary tasks. Mov Disord (2007) 0.81
Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea. J Neurol (2011) 0.81
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease. Neurodegener Dis Manag (2012) 0.81
Dopamine dysregulation syndrome and deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurol Res Int (2011) 0.81
Defining a role for the subthalamic nucleus within operative theoretical models of subcortical participation in language. J Neurol Neurosurg Psychiatry (2003) 0.81
Characterizing the spiking dynamics of subthalamic nucleus neurons in Parkinson's disease using generalized linear models. Front Integr Neurosci (2012) 0.80
Brain energization in response to deep brain stimulation of subthalamic nuclei in Parkinson's disease. J Cereb Blood Flow Metab (2011) 0.79
Posteroventral medial pallidotomy in Parkinson's disease. J Neurol (1999) 0.78
Subthalamic nucleus high-frequency stimulation restores altered electrophysiological properties of cortical neurons in parkinsonian rat. PLoS One (2013) 0.78
The effects of Parkinson's disease and age on syncopated finger movements. Brain Res (2009) 0.78
Vascular changes caused by deep brain stimulation using double-dose gadolinium-enhanced brain MRI. Neural Regen Res (2014) 0.78
Pallidal stimulation suppresses pathological dysrhythmia in the parkinsonian motor cortex. J Neurophysiol (2015) 0.78
Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease. Mov Disord (2012) 0.77
Predictive potential of pre-operative functional neuroimaging in patients treated with subthalamic stimulation. Eur J Nucl Med Mol Imaging (2010) 0.77
Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson's disease. J Neurol (2005) 0.76
Feasibility of using linearly polarized rotating birdcage transmitters and close-fitting receive arrays in MRI to reduce SAR in the vicinity of deep brain simulation implants. Magn Reson Med (2016) 0.76
Impaired performance on the Wisconsin Card Sorting Test under left- when compared to right-sided deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol (2009) 0.76
Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders. World J Radiol (2014) 0.76
Suppression of deep brain stimulation artifacts from the electroencephalogram by frequency-domain Hampel filtering. Clin Neurophysiol (2010) 0.76
Are there adaptive changes in the human brain of patients with Parkinson's disease treated with long-term deep brain stimulation of the subthalamic nucleus? A 4-year follow-up study with regional cerebral blood flow SPECT. Eur J Nucl Med Mol Imaging (2007) 0.76
Network effects of deep brain stimulation. J Neurophysiol (2015) 0.75
Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation. Int J Biomed Imaging (2008) 0.75
Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease. Neurosci Bull (2014) 0.75
The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease. Exp Brain Res (2016) 0.75
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. JCI Insight (2017) 0.75
Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 0.75
In Parkinson's disease pallidal deep brain stimulation speeds up response initiation but has no effect on reactive inhibition. J Neurol (2015) 0.75
Rapid Alleviation of Parkinson's Disease Symptoms via Electrostimulation of Intrinsic Auricular Muscle Zones. Front Hum Neurosci (2017) 0.75
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Randomized trial of group therapy for repeated deliberate self-harm in adolescents. J Am Acad Child Adolesc Psychiatry (2001) 3.89
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother (2001) 3.87
Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol (2001) 3.67
The anatomy of phonological and semantic processing in normal subjects. Brain (1992) 3.41
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
Brain regions involved in articulation. Lancet (1999) 2.97
Reproductive behavior and health in consanguineous marriages. Science (1991) 2.75
Identifying global anatomical differences: deformation-based morphometry. Hum Brain Mapp (1998) 2.74
Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity (1996) 2.74
Distribution of cortical neural networks involved in word comprehension and word retrieval. Brain (1991) 2.66
Mental health needs of boys in secure care for serious or persistent offending: a prospective, longitudinal study. Lancet (2002) 2.64
'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport (1996) 2.60
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45
Transcranial magnetic stimulation in cognitive neuroscience--virtual lesion, chronometry, and functional connectivity. Curr Opin Neurobiol (2000) 2.35
Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant (2006) 2.32
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter. Mol Cell Biol (1987) 2.17
Multidimensional Treatment Foster Care for Adolescents in English care: randomised trial and observational cohort evaluation. Br J Psychiatry (2013) 2.16
The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Representation of the temporal envelope of sounds in the human brain. J Neurophysiol (2000) 1.96
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
The cortical localization of the lexicons. Positron emission tomography evidence. Brain (1992) 1.91
Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology (2002) 1.89
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
Intestinal permeability and screening tests for coeliac disease. Gut (1980) 1.81
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66
Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut (1982) 1.65
The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans. Neuroreport (1999) 1.59
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56
Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. BMJ (2011) 1.55
Cellobiose/mannitol sugar test--a sensitive tubeless test for coeliac disease: results on 1010 unselected patients. Gut (1989) 1.55
Lateropulsion, pushing and verticality perception in hemisphere stroke: a causal relationship? Brain (2008) 1.50
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Acute pancreatitis following endoscopic retrograde cholangiopancreatography. Clin Radiol (1983) 1.49
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord (1998) 1.47
Identification of common functional configurations among molecules. J Chem Inf Comput Sci (1996) 1.45
Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43
Non-invasive magnetic stimulation of the human cerebellum facilitates cortico-bulbar projections in the swallowing motor system. Neurogastroenterol Motil (2011) 1.43
Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42
A performance indicator of psychosocial services in enhanced prenatal care of Medicaid-eligible women. Matern Child Health J (1998) 1.41
Detection of thirty-second cognitive activations in single subjects with positron emission tomography: a new low-dose H2(15)O regional cerebral blood flow three-dimensional imaging technique. J Cereb Blood Flow Metab (1993) 1.41
Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41
[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
A developing crisis. Staffing overshadows all other challenges facing radiology departments. Hosp Health Netw (2001) 1.39
Unexpected behavior of heavy-ion fusion cross sections at extreme sub-barrier energies. Phys Rev Lett (2002) 1.39
Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Brain (1996) 1.38
Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology (1989) 1.38
Passive permeability in experimental intestinal damage in rats. Clin Sci (Lond) (1981) 1.38
Modulation of cell firing in the nucleus accumbens. Ann N Y Acad Sci (1999) 1.33
9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.32
Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28
Homeless and runaway youths' access to health care. J Adolesc Health (2000) 1.28
Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet (1979) 1.27
Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther (2001) 1.26
Intestinal permeability in rats infected by Nippostrongylus brasiliensis. Gut (1979) 1.25
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J (1998) 1.25
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J (1992) 1.24
Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain (2003) 1.23
Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23
Maternal cocaine use and infant behavior. Neurotoxicol Teratol (1991) 1.21
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med (1994) 1.20
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
The economics of febrile neutropenia: implications for the use of colony-stimulating factors. Eur J Cancer (1998) 1.19
Oral mucosal lesions found in smokeless tobacco users. J Am Dent Assoc (1990) 1.19
Regional response differences within the human auditory cortex when listening to words. Neurosci Lett (1992) 1.19
Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) (1993) 1.18
Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17